A carregar...
Metformin suppresses cancer initiation and progression in genetic mouse models of pancreatic cancer
BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) is the fourth leading cause of cancer-associated mortality worldwide with an overall five-year survival rate less than 7%. Accumulating evidence has revealed the cancer preventive and therapeutic effects of metformin, one of the most widely prescri...
Na minha lista:
| Publicado no: | Mol Cancer |
|---|---|
| Main Authors: | , , , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5525317/ https://ncbi.nlm.nih.gov/pubmed/28738823 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12943-017-0701-0 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|